Literature DB >> 30651246

Haematology: multiple myeloma.

John Firth.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30651246      PMCID： PMC6399642          DOI： 10.7861/clinmedicine.19-1-58

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  13 in total

1.  The use of whole-body MRI in multiple myeloma.

Authors:  Mark Portet; Emma Owens; David Howlett
Journal:  Clin Med (Lond)       Date:  2019-07       Impact factor: 2.659

2.  Haematology: Multiple Myeloma.

Authors:  Jonathan Cullis
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

3.  All change, all change.

Authors:  Ed Nicol
Journal:  Clin Med (Lond)       Date:  2019-01       Impact factor: 2.659

Review 4.  Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management Strategies.

Authors:  Xiang Zhou; Leo Rasche; K Martin Kortüm; Sophia Danhof; Michael Hudecek; Hermann Einsele
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

Review 5.  Perspectives for the Use of CAR-T Cells for the Treatment of Multiple Myeloma.

Authors:  Marcin Jasiński; Grzegorz W Basak; Wiesław W Jedrzejczak
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

6.  Huanglian Jiedu Decoction for treatment of multiple myeloma: A protocol for a systematic review and meta-analysis.

Authors:  Na An; Yiwei Li; Xilian Huang; Can Chen; Yaping Xie
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

Review 7.  Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management.

Authors:  Sumana Kundu; Surajkumar B Jha; Ana P Rivera; Gabriela V Flores Monar; Hamza Islam; Sri Madhurima Puttagunta; Rabia Islam; Ibrahim Sange
Journal:  Cureus       Date:  2022-02-25

8.  Effect of Autologous Stem Cell Transplantation Combined with Modified VTD Regimen on Elderly Patients with Multiple Myeloma and Its Influence on miRNA Cytokines.

Authors:  Zhaoliang Bai; Jiansong Shen
Journal:  Comput Math Methods Med       Date:  2022-02-16       Impact factor: 2.238

9.  ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype.

Authors:  Tingting Yu; Lan Yao; Hua Yin; Yao Teng; Mei Hong; Qiuling Wu
Journal:  Int J Biol Sci       Date:  2022-03-06       Impact factor: 6.580

10.  Inhibition of Cytosolic Phospholipase A2α Induces Apoptosis in Multiple Myeloma Cells.

Authors:  Nur Mahammad; Felicity J Ashcroft; Astrid J Feuerherm; Samah Elsaadi; Esten N Vandsemb; Magne Børset; Berit Johansen
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.